Cariprazine + Mao Inhibitors Interaction
Moderateinteraction on record
Description
Concomitant use increases exposures of cariprazine and its active metabolite didesmethylcariprazine. VRAYLAR dosage reduction is recommended.
Mechanism
CYP3A4 inhibition increases cariprazine and DDCAR exposure
Source: NLP:cariprazine